Abstract: Opioid-induced constipation (OIC) is an increasingly prevalent problem in the USA due to the growing use of opioids. A novel class of therapeutics, the peripherally acting μ-opioid receptor antagonists (PAMORAs), has been developed to mitigate the deleterious effects of opioids in the ...
Spotlight on naldemedine in the treatment of opioid-induced constipation in adult patients with ...
- Written by: Norris Garman
- Category: Drug News
- Hits: 838